CLN3 disease process: missense point mutations and protein depletion in vitro
Although the CLN3 gene associated with the disease process in subjects with the juvenile form of neuronal ceroid lipofuscinosis was discovered in 1995, our knowledge of the physiological function of its gene product, CLN3 protein, is still incomplete. To gain more insight into the structural propert...
Saved in:
Published in | European journal of paediatric neurology Vol. 5; pp. 81 - 88 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Elsevier Ltd
2001
|
Subjects | |
Online Access | Get full text |
ISSN | 1090-3798 1532-2130 |
DOI | 10.1053/ejpn.2000.0440 |
Cover
Abstract | Although the
CLN3 gene associated with the disease process in subjects with the juvenile form of neuronal ceroid lipofuscinosis was discovered in 1995, our knowledge of the physiological function of its gene product, CLN3 protein, is still incomplete. To gain more insight into the structural properties and function of CLN3 protein we studied at present: i) how the naturally occurring point mutations
Arg334Cys and
Leu101Pro affect the biological properties of CLN3 protein, and ii) whether depletion of CLN3 protein synthesis by using an antisense approach induces a distinct phenotype in cells of neuronal origin
in vitro. Here we report that although both
CLN3 mutant proteins are targeted to lysosomes, thus similar to wild-type CLN3 protein, they are devoid of the biological activity of wild-type CLN3 protein such as its effect on lysosomal pH or intracellular processing of amyloid-
β protein precursor and cathepsin D
in vitro. The
Leu101 Pro mutation affected significantly the maturation and stability of
CLN3 protein. The
Arg334Cys mutation influenced mildly the maturation and turnover of CLN3 protein, but at the same time abolished the function of CLN3 protein in vitro, which suggests that the
Arg334 may constitute a part of the active site of CLN3 protein. In addition, we show that depletion of CLN3 protein synthesis in human neuroblastoma cells
in vitro induces outgrowth of long cellular processes and formation of cellular aggregates and affects the viability of these cells. This finding suggests that CLN3 protein is implicated in biological processes associated with the differentiation of cells of neuronal origin. |
---|---|
AbstractList | Although the CLN3 gene associated with the disease process in subjects with the juvenile form of neuronal ceroid lipofuscinosis was discovered in 1995, our knowledge of the physiological function of its gene product, CLN3 protein, is still incomplete. To gain more insight into the structural properties and function of CLN3 protein we studied at present: i) how the naturally occurring point mutations Arg334Cys and Leu101Pro affect the biological properties of CLN3 protein, and ii) whether depletion of CLN3 protein synthesis by using an antisense approach induces a distinct phenotype in cells of neuronal origin in vitro. Here we report that although both CLN3 mutant proteins are targeted to lysosomes, thus similar to wild-type CLN3 protein, they are devoid of the biological activity of wild-type CLN3 protein such as its effect on lysosomal pH or intracellular processing of amyloid-beta protein precursor and cathepsin D in vitro. The Leu101Pro mutation affected significantly the maturation and stability of CLN3 protein. The Arg334Cys mutation influenced mildly the maturation and turnover of CLN3 protein, but at the same time abolished the function of CLN3 protein in vitro, which suggests that the Arg334 may constitute a part of the active site of CLN3 protein. In addition, we show that depletion of CLN3 protein synthesis in human neuroblastoma cells in vitro induces outgrowth of long cellular processes and formation of cellular aggregates and affects the viability of these cells. This finding suggests that CLN3 protein is implicated in biological processes associated with the differentiation of cells of neuronal origin. Although the CLN3 gene associated with the disease process in subjects with the juvenile form of neuronal ceroid lipofuscinosis was discovered in 1995, our knowledge of the physiological function of its gene product, CLN3 protein, is still incomplete. To gain more insight into the structural properties and function of CLN3 protein we studied at present: i) how the naturally occurring point mutations Arg334Cys and Leu101Pro affect the biological properties of CLN3 protein, and ii) whether depletion of CLN3 protein synthesis by using an antisense approach induces a distinct phenotype in cells of neuronal origin in vitro. Here we report that although both CLN3 mutant proteins are targeted to lysosomes, thus similar to wild-type CLN3 protein, they are devoid of the biological activity of wild-type CLN3 protein such as its effect on lysosomal pH or intracellular processing of amyloid- β protein precursor and cathepsin D in vitro. The Leu101 Pro mutation affected significantly the maturation and stability of CLN3 protein. The Arg334Cys mutation influenced mildly the maturation and turnover of CLN3 protein, but at the same time abolished the function of CLN3 protein in vitro, which suggests that the Arg334 may constitute a part of the active site of CLN3 protein. In addition, we show that depletion of CLN3 protein synthesis in human neuroblastoma cells in vitro induces outgrowth of long cellular processes and formation of cellular aggregates and affects the viability of these cells. This finding suggests that CLN3 protein is implicated in biological processes associated with the differentiation of cells of neuronal origin. Although the CLN3 gene associated with the disease process in subjects with the juvenile form of neuronal ceroid lipofuscinosis was discovered in 1995, our knowledge of the physiological function of its gene product, CLN3 protein, is still incomplete. To gain more insight into the structural properties and function of CLN3 protein we studied at present: i) how the naturally occurring point mutations Arg334Cys and Leu101Pro affect the biological properties of CLN3 protein, and ii) whether depletion of CLN3 protein synthesis by using an antisense approach induces a distinct phenotype in cells of neuronal origin in vitro. Here we report that although both CLN3 mutant proteins are targeted to lysosomes, thus similar to wild-type CLN3 protein, they are devoid of the biological activity of wild-type CLN3 protein such as its effect on lysosomal pH or intracellular processing of amyloid-beta protein precursor and cathepsin D in vitro. The Leu101Pro mutation affected significantly the maturation and stability of CLN3 protein. The Arg334Cys mutation influenced mildly the maturation and turnover of CLN3 protein, but at the same time abolished the function of CLN3 protein in vitro, which suggests that the Arg334 may constitute a part of the active site of CLN3 protein. In addition, we show that depletion of CLN3 protein synthesis in human neuroblastoma cells in vitro induces outgrowth of long cellular processes and formation of cellular aggregates and affects the viability of these cells. This finding suggests that CLN3 protein is implicated in biological processes associated with the differentiation of cells of neuronal origin.Although the CLN3 gene associated with the disease process in subjects with the juvenile form of neuronal ceroid lipofuscinosis was discovered in 1995, our knowledge of the physiological function of its gene product, CLN3 protein, is still incomplete. To gain more insight into the structural properties and function of CLN3 protein we studied at present: i) how the naturally occurring point mutations Arg334Cys and Leu101Pro affect the biological properties of CLN3 protein, and ii) whether depletion of CLN3 protein synthesis by using an antisense approach induces a distinct phenotype in cells of neuronal origin in vitro. Here we report that although both CLN3 mutant proteins are targeted to lysosomes, thus similar to wild-type CLN3 protein, they are devoid of the biological activity of wild-type CLN3 protein such as its effect on lysosomal pH or intracellular processing of amyloid-beta protein precursor and cathepsin D in vitro. The Leu101Pro mutation affected significantly the maturation and stability of CLN3 protein. The Arg334Cys mutation influenced mildly the maturation and turnover of CLN3 protein, but at the same time abolished the function of CLN3 protein in vitro, which suggests that the Arg334 may constitute a part of the active site of CLN3 protein. In addition, we show that depletion of CLN3 protein synthesis in human neuroblastoma cells in vitro induces outgrowth of long cellular processes and formation of cellular aggregates and affects the viability of these cells. This finding suggests that CLN3 protein is implicated in biological processes associated with the differentiation of cells of neuronal origin. |
Author | Golabek, Adam A. Wisniewski, Krystyna E. Walus, Mariusz Kaczmarski, Wojciech Kida, Elizabeth Wujek, Piotr |
Author_xml | – sequence: 1 givenname: Adam A. surname: Golabek fullname: Golabek, Adam A. email: golabekc@popmail.med.nyu.edu – sequence: 2 givenname: Elizabeth surname: Kida fullname: Kida, Elizabeth – sequence: 3 givenname: Mariusz surname: Walus fullname: Walus, Mariusz – sequence: 4 givenname: Wojciech surname: Kaczmarski fullname: Kaczmarski, Wojciech – sequence: 5 givenname: Piotr surname: Wujek fullname: Wujek, Piotr – sequence: 6 givenname: Krystyna E. surname: Wisniewski fullname: Wisniewski, Krystyna E. |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/11589014$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kNtLwzAUh4Mo7qKvPkqffGvNrWvrmwxvMPVFn0OWnEJmm9YkG-y_N2UTYTAhkJPD9x1OfhN0ajsLCF0RnBGcs1tY9TajGOMMc45P0JjkjKaUMHwaa1zhlBVVOUIT71eRqjidnaMRIXlZYcLH6HW-eGOJNh6kh6R3nQLv75LWeA926HTGhqRdBxlMZ30irR6oAMYmGvoGhnYSHxsTXHeBzmrZeLjc31P0-fjwMX9OF-9PL_P7RaoYpiFlVSF1RXldc1lrBbrOlyVhJCeU1TVTjNKqYKAIl7GSVGnNKMezijAqJcZsim52c-Mq32vwQcSFFTSNtNCtvSgoKeMZwOs9uF62oEXvTCvdVvwGEIFsByjXee-g_kOwGBIWQ8JiSFgMCUeBHwjK7MIJTprmuFbuNIixbAw44ZUBG_9uHKggdGeOq7MDVTXGGiWbL9j-J_4ABfmkkQ |
CitedBy_id | crossref_primary_10_1016_j_neulet_2021_136117 crossref_primary_10_1097_00019052_200112000_00019 crossref_primary_10_2217_clp_11_70 |
Cites_doi | 10.1016/0092-8674(95)90274-0 10.1038/8861 10.1093/hmg/8.6.1091 10.1006/mgme.1999.2834 10.1002/ana.410430118 10.1093/hmg/9.5.735 10.1055/s-2007-973663 10.1006/bbrc.1998.9272 10.1093/hmg/8.3.523 10.1212/WNL.52.2.360 10.1006/mgme.1999.2833 10.1016/S0014-5793(98)01425-2 10.1006/mgme.1999.2836 10.1006/mgme.1999.2837 10.1006/mgme.2000.3006 10.1093/hmg/7.1.85 10.1086/514846 10.1006/bbrc.1998.9210 10.1007/s004390050654 |
ContentType | Journal Article |
Copyright | 2001 European Paediatric Neurology Society |
Copyright_xml | – notice: 2001 European Paediatric Neurology Society |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1053/ejpn.2000.0440 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1532-2130 |
EndPage | 88 |
ExternalDocumentID | 11589014 10_1053_ejpn_2000_0440 S1090379805800169 |
Genre | Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S Journal Article |
GrantInformation_xml | – fundername: NINDS NIH HHS grantid: NS38988 |
GroupedDBID | --- --K --M .1- .FO .~1 0R~ 1B1 1P~ 1~. 1~5 4.4 457 4G. 53G 5GY 5VS 7-5 71M 8P~ AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAXKI AAXLA AAXUO AAYWO ABBQC ABCQJ ABFNM ABJNI ABMAC ABMZM ABTEW ABWVN ABXDB ACDAQ ACGFS ACIEU ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO AEBSH AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGQPQ AGUBO AGWIK AGYEJ AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CAG COF CS3 DU5 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-Q GBLVA HVGLF HZ~ IHE J1W KOM M41 MO0 MOBAO N9A O-L O9- OAUVE OP~ OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SDF SDG SEL SES SEW SPCBC SSH SSN SSZ T5K Z5R ~G- AACTN AADPK AAIAV ABLVK ABYKQ AFCTW AFKWA AJBFU AJOXV AMFUW EFLBG LCYCR RIG AAYXX AGRNS CITATION CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c302t-397ad924ff4afdcedf5b81315123ff3c322973ec14a229a2cdd324069132aa003 |
IEDL.DBID | .~1 |
ISSN | 1090-3798 |
IngestDate | Thu Sep 04 16:55:19 EDT 2025 Mon Jul 21 05:58:07 EDT 2025 Thu Apr 24 22:59:26 EDT 2025 Tue Jul 01 00:19:54 EDT 2025 Fri Feb 23 02:35:25 EST 2024 Tue Aug 26 16:32:13 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | CLN3 Mutations Cell culture Overexpression Antisense experiments |
Language | English |
License | https://www.elsevier.com/tdm/userlicense/1.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c302t-397ad924ff4afdcedf5b81315123ff3c322973ec14a229a2cdd324069132aa003 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 11589014 |
PQID | 72182180 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_72182180 pubmed_primary_11589014 crossref_primary_10_1053_ejpn_2000_0440 crossref_citationtrail_10_1053_ejpn_2000_0440 elsevier_sciencedirect_doi_10_1053_ejpn_2000_0440 elsevier_clinicalkey_doi_10_1053_ejpn_2000_0440 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2001 2001-1-00 2001-00-00 20010101 |
PublicationDateYYYYMMDD | 2001-01-01 |
PublicationDate_xml | – year: 2001 text: 2001 |
PublicationDecade | 2000 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | European journal of paediatric neurology |
PublicationTitleAlternate | Eur J Paediatr Neurol |
PublicationYear | 2001 |
Publisher | Elsevier Ltd |
Publisher_xml | – name: Elsevier Ltd |
References | Järvelä, Sainio, Rantamaki (bib9) 1998; 7 Kaczmarski, Wisniewski, Golabek (bib6) 1999; 66 Croopnick, Choi, Muller (bib11) 1998; 250 Pearce, Ferea, Nosel (bib12) 1999; 22 Michalewski, Kaczmarski, Golabek (bib5) 1998; 253 Zhong, Wisniewski, Kaczmarski (bib21) 1998; 102 Sidell, Sarafian, Kelly (bib27) 1986; 54 Ohkuma, Moriyama, Takano (bib25) 1982; 79 Kremmidiotis, Lensink, Bilton (bib13) 1999; 8 Järvelä, Lehtovirta, Tikkanen (bib15) 1999; 8 Pearce, Carr, Das, Sherman (bib17) 1999; 96 Lauronen, Munroe, Järvelä (bib22) 1999; 2 Batten (bib1) 1903; 23 Towbin, Staehelin, Gordon (bib23) 1979; 76 Wisniewski, Zhong, Kaczmarski (bib20) 1998; 43 The International Batten Disease Consortium (bib2) 1995; 82 Munroe, Mitchison, O'Rawe (bib19) 1997; 61 Ohkuma, Poole (bib24) 1978; 75 Forgac (bib26) 1998; 440 Kaczmarski, Kida, Lach (bib3) 1997; 28 Kida, Kaczmarski, Golabek (bib7) 1999; 66 Katz, Gao, Prabhakaram (bib14) 1997; 38 Haskell, Carr, Pearce (bib10) 2000; 9 Pearce, Sherman (bib16) 1998; 95 Golabek, Kaczmarski, Kida (bib4) 1999; 66 Puranam, Guo, Qian (bib18) 1999; 66 Golabek, Kida, Walus (bib8) 2000; 70 Croopnick (10.1053/ejpn.2000.0440_bib11) 1998; 250 Katz (10.1053/ejpn.2000.0440_bib14) 1997; 38 The International Batten Disease Consortium (10.1053/ejpn.2000.0440_bib2) 1995; 82 Pearce (10.1053/ejpn.2000.0440_bib17) 1999; 96 Michalewski (10.1053/ejpn.2000.0440_bib5) 1998; 253 Munroe (10.1053/ejpn.2000.0440_bib19) 1997; 61 Kida (10.1053/ejpn.2000.0440_bib7) 1999; 66 Puranam (10.1053/ejpn.2000.0440_bib18) 1999; 66 Sidell (10.1053/ejpn.2000.0440_bib27) 1986; 54 Forgac (10.1053/ejpn.2000.0440_bib26) 1998; 440 Golabek (10.1053/ejpn.2000.0440_bib8) 2000; 70 Ohkuma (10.1053/ejpn.2000.0440_bib25) 1982; 79 Kaczmarski (10.1053/ejpn.2000.0440_bib6) 1999; 66 Pearce (10.1053/ejpn.2000.0440_bib12) 1999; 22 Järvelä (10.1053/ejpn.2000.0440_bib9) 1998; 7 Lauronen (10.1053/ejpn.2000.0440_bib22) 1999; 2 Kaczmarski (10.1053/ejpn.2000.0440_bib3) 1997; 28 Batten (10.1053/ejpn.2000.0440_bib1) 1903; 23 Haskell (10.1053/ejpn.2000.0440_bib10) 2000; 9 Järvelä (10.1053/ejpn.2000.0440_bib15) 1999; 8 Golabek (10.1053/ejpn.2000.0440_bib4) 1999; 66 Wisniewski (10.1053/ejpn.2000.0440_bib20) 1998; 43 Towbin (10.1053/ejpn.2000.0440_bib23) 1979; 76 Ohkuma (10.1053/ejpn.2000.0440_bib24) 1978; 75 Pearce (10.1053/ejpn.2000.0440_bib16) 1998; 95 Zhong (10.1053/ejpn.2000.0440_bib21) 1998; 102 Kremmidiotis (10.1053/ejpn.2000.0440_bib13) 1999; 8 |
References_xml | – volume: 28 start-page: 33 year: 1997 end-page: 36 ident: bib3 article-title: Expression studies of CLN3 protein publication-title: Neuropediatrics – volume: 96 start-page: 11341 year: 1999 end-page: 11345 ident: bib17 article-title: Phenotypic reversal of the btnl defects in yeast by chloroquine: A yeast model for Batten disease publication-title: Proc Natl Acad Sci USA – volume: 102 start-page: 57 year: 1998 end-page: 62 ident: bib21 article-title: Molecular screening of Batten disease: identification of a missense mutation (E295K) in the CLN3 gene publication-title: Hum Genet – volume: 38 start-page: 2375 year: 1997 end-page: 2386 ident: bib14 article-title: Immunochemical localization of the Batten disease (CLN3) protein in retina publication-title: Invest Ophthalmol Vis Sci – volume: 82 start-page: 949 year: 1995 end-page: 957 ident: bib2 article-title: Isolation of a novel gene underlying Batten disease, CLN3 publication-title: Cell – volume: 8 start-page: 523 year: 1999 end-page: 531 ident: bib13 article-title: The Batten disease gene product (CLN3p) is a Golgi integral membrane protein publication-title: Hum Mol Genet – volume: 76 start-page: 4350 year: 1979 end-page: 4359 ident: bib23 article-title: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets:procedure and some applications publication-title: Proc Natl Acad Sci USA – volume: 70 start-page: 203 year: 2000 end-page: 213 ident: bib8 article-title: CLN3 protein regulates lysosomal pH and alters intracellular processing of Alzheimer's amyloid- publication-title: Mol Genet Metab – volume: 8 start-page: 1091 year: 1999 end-page: 1098 ident: bib15 article-title: Defective intracellular transport of CLN3 is the molecular basis of Batten disease (JNCL) publication-title: Hum Mol Genet – volume: 75 start-page: 3327 year: 1978 end-page: 3331 ident: bib24 article-title: Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents publication-title: Proc Natl Acad Sci USA – volume: 43 start-page: 106 year: 1998 end-page: 110 ident: bib20 article-title: Compound heterozygous genotype is associated with protracted juvenile neuronal ceroid lipofuscinosis publication-title: Ann Neurol – volume: 66 start-page: 294 year: 1999 end-page: 308 ident: bib18 article-title: Cln3 defines a novel antiapoptotic pathway operative in neurodegeneration and mediated by ceramide publication-title: Mol Genet Metab – volume: 61 start-page: 310 year: 1997 end-page: 316 ident: bib19 article-title: Spectrum of mutations in the Batten disease gene, CLN3 publication-title: Am J Hum Genet – volume: 79 start-page: 2758 year: 1982 end-page: 2762 ident: bib25 article-title: Identification and characterization of a proton pump on lysosomes by fluorescein-isothiocyanate-dextran fluorescence publication-title: Proc Natl Acad Sci USA – volume: 66 start-page: 277 year: 1999 end-page: 282 ident: bib4 article-title: Expression studies of CLN3 protein associated with a juvenile form of neuronal ceroid lipofuscinosis in mammalian cells publication-title: Mol Genet Metab – volume: 7 start-page: 85 year: 1998 end-page: 90 ident: bib9 article-title: Biosynthesis and intracellular targeting of the CLN3 protein defective in Batten disease publication-title: Hum Mol Genet – volume: 250 start-page: 335 year: 1998 end-page: 341 ident: bib11 article-title: The subcellular location of the yeast Saccharomyces cerevisiae homologue of the protein defective in juvenile form of Batten disease publication-title: Biochem Biophys Res Comm – volume: 440 start-page: 258 year: 1998 end-page: 263 ident: bib26 article-title: Structure, function and regulation of the vacuolar (H+)-ATPases publication-title: FEBS Lett – volume: 66 start-page: 261 year: 1999 end-page: 264 ident: bib6 article-title: Studies of membrane association of CLN3 protein publication-title: Mol Genet Metab – volume: 22 start-page: 55 year: 1999 end-page: 58 ident: bib12 article-title: Action of BTN1, the yeast orthologue of the gene mutated in Batten disease publication-title: Nature Gen – volume: 54 start-page: 287 year: 1986 end-page: 300 ident: bib27 article-title: Retinoic acidinduced differentiation of human neuroblastoma: a cell variant system showing two distinct responses publication-title: Exp Cell Biol – volume: 253 start-page: 458 year: 1998 end-page: 462 ident: bib5 article-title: Evidence for phosphorylation of CLN3 protein associated with Batten disease publication-title: Biochem Biophys Res Commun – volume: 66 start-page: 265 year: 1999 end-page: 271 ident: bib7 article-title: Analysis of intracellular distribution and trafficking of the CLN3 protein in fusion with the green fluorescent protein in vitro publication-title: Mol Genet Metab – volume: 9 start-page: 735 year: 2000 end-page: 744 ident: bib10 article-title: Batten disease: evaluation of CLN3 mutations on protein localization and function publication-title: Hum Mol Genet – volume: 2 start-page: 360 year: 1999 end-page: 365 ident: bib22 article-title: Delayed classic and protracted phenotypes of compound heterozygous juvenile neuronal ceroid lipofuscinosis publication-title: Neurology – volume: 95 start-page: 6915 year: 1998 end-page: 6918 ident: bib16 article-title: A yeast model for the study of Batten disease publication-title: Proc Natl Acad Sci USA – volume: 23 start-page: 386 year: 1903 end-page: 390 ident: bib1 article-title: Cerebral degeneration with etrical changes in the maculae in two members of a family publication-title: Trans Ophthalmol Soc UK – volume: 75 start-page: 3327 year: 1978 ident: 10.1053/ejpn.2000.0440_bib24 article-title: Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents – volume: 82 start-page: 949 year: 1995 ident: 10.1053/ejpn.2000.0440_bib2 article-title: Isolation of a novel gene underlying Batten disease, CLN3 publication-title: Cell doi: 10.1016/0092-8674(95)90274-0 – volume: 22 start-page: 55 year: 1999 ident: 10.1053/ejpn.2000.0440_bib12 article-title: Action of BTN1, the yeast orthologue of the gene mutated in Batten disease publication-title: Nature Gen doi: 10.1038/8861 – volume: 38 start-page: 2375 year: 1997 ident: 10.1053/ejpn.2000.0440_bib14 article-title: Immunochemical localization of the Batten disease (CLN3) protein in retina publication-title: Invest Ophthalmol Vis Sci – volume: 8 start-page: 1091 year: 1999 ident: 10.1053/ejpn.2000.0440_bib15 article-title: Defective intracellular transport of CLN3 is the molecular basis of Batten disease (JNCL) publication-title: Hum Mol Genet doi: 10.1093/hmg/8.6.1091 – volume: 66 start-page: 294 year: 1999 ident: 10.1053/ejpn.2000.0440_bib18 article-title: Cln3 defines a novel antiapoptotic pathway operative in neurodegeneration and mediated by ceramide publication-title: Mol Genet Metab doi: 10.1006/mgme.1999.2834 – volume: 43 start-page: 106 year: 1998 ident: 10.1053/ejpn.2000.0440_bib20 article-title: Compound heterozygous genotype is associated with protracted juvenile neuronal ceroid lipofuscinosis publication-title: Ann Neurol doi: 10.1002/ana.410430118 – volume: 9 start-page: 735 year: 2000 ident: 10.1053/ejpn.2000.0440_bib10 article-title: Batten disease: evaluation of CLN3 mutations on protein localization and function publication-title: Hum Mol Genet doi: 10.1093/hmg/9.5.735 – volume: 28 start-page: 33 year: 1997 ident: 10.1053/ejpn.2000.0440_bib3 article-title: Expression studies of CLN3 protein publication-title: Neuropediatrics doi: 10.1055/s-2007-973663 – volume: 96 start-page: 11341 year: 1999 ident: 10.1053/ejpn.2000.0440_bib17 article-title: Phenotypic reversal of the btnl defects in yeast by chloroquine: A yeast model for Batten disease – volume: 250 start-page: 335 year: 1998 ident: 10.1053/ejpn.2000.0440_bib11 article-title: The subcellular location of the yeast Saccharomyces cerevisiae homologue of the protein defective in juvenile form of Batten disease publication-title: Biochem Biophys Res Comm doi: 10.1006/bbrc.1998.9272 – volume: 8 start-page: 523 year: 1999 ident: 10.1053/ejpn.2000.0440_bib13 article-title: The Batten disease gene product (CLN3p) is a Golgi integral membrane protein publication-title: Hum Mol Genet doi: 10.1093/hmg/8.3.523 – volume: 95 start-page: 6915 year: 1998 ident: 10.1053/ejpn.2000.0440_bib16 article-title: A yeast model for the study of Batten disease – volume: 79 start-page: 2758 year: 1982 ident: 10.1053/ejpn.2000.0440_bib25 article-title: Identification and characterization of a proton pump on lysosomes by fluorescein-isothiocyanate-dextran fluorescence – volume: 2 start-page: 360 year: 1999 ident: 10.1053/ejpn.2000.0440_bib22 article-title: Delayed classic and protracted phenotypes of compound heterozygous juvenile neuronal ceroid lipofuscinosis publication-title: Neurology doi: 10.1212/WNL.52.2.360 – volume: 54 start-page: 287 year: 1986 ident: 10.1053/ejpn.2000.0440_bib27 article-title: Retinoic acidinduced differentiation of human neuroblastoma: a cell variant system showing two distinct responses publication-title: Exp Cell Biol – volume: 66 start-page: 261 year: 1999 ident: 10.1053/ejpn.2000.0440_bib6 article-title: Studies of membrane association of CLN3 protein publication-title: Mol Genet Metab doi: 10.1006/mgme.1999.2833 – volume: 440 start-page: 258 year: 1998 ident: 10.1053/ejpn.2000.0440_bib26 article-title: Structure, function and regulation of the vacuolar (H+)-ATPases publication-title: FEBS Lett doi: 10.1016/S0014-5793(98)01425-2 – volume: 66 start-page: 277 year: 1999 ident: 10.1053/ejpn.2000.0440_bib4 article-title: Expression studies of CLN3 protein associated with a juvenile form of neuronal ceroid lipofuscinosis in mammalian cells publication-title: Mol Genet Metab doi: 10.1006/mgme.1999.2836 – volume: 23 start-page: 386 year: 1903 ident: 10.1053/ejpn.2000.0440_bib1 article-title: Cerebral degeneration with etrical changes in the maculae in two members of a family publication-title: Trans Ophthalmol Soc UK – volume: 66 start-page: 265 year: 1999 ident: 10.1053/ejpn.2000.0440_bib7 article-title: Analysis of intracellular distribution and trafficking of the CLN3 protein in fusion with the green fluorescent protein in vitro publication-title: Mol Genet Metab doi: 10.1006/mgme.1999.2837 – volume: 70 start-page: 203 year: 2000 ident: 10.1053/ejpn.2000.0440_bib8 article-title: CLN3 protein regulates lysosomal pH and alters intracellular processing of Alzheimer's amyloid-β protein precursor and cathepsin D in humancells publication-title: Mol Genet Metab doi: 10.1006/mgme.2000.3006 – volume: 7 start-page: 85 year: 1998 ident: 10.1053/ejpn.2000.0440_bib9 article-title: Biosynthesis and intracellular targeting of the CLN3 protein defective in Batten disease publication-title: Hum Mol Genet doi: 10.1093/hmg/7.1.85 – volume: 61 start-page: 310 year: 1997 ident: 10.1053/ejpn.2000.0440_bib19 article-title: Spectrum of mutations in the Batten disease gene, CLN3 publication-title: Am J Hum Genet doi: 10.1086/514846 – volume: 253 start-page: 458 year: 1998 ident: 10.1053/ejpn.2000.0440_bib5 article-title: Evidence for phosphorylation of CLN3 protein associated with Batten disease publication-title: Biochem Biophys Res Commun doi: 10.1006/bbrc.1998.9210 – volume: 102 start-page: 57 year: 1998 ident: 10.1053/ejpn.2000.0440_bib21 article-title: Molecular screening of Batten disease: identification of a missense mutation (E295K) in the CLN3 gene publication-title: Hum Genet doi: 10.1007/s004390050654 – volume: 76 start-page: 4350 year: 1979 ident: 10.1053/ejpn.2000.0440_bib23 article-title: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets:procedure and some applications |
SSID | ssj0009426 |
Score | 1.5542349 |
Snippet | Although the
CLN3 gene associated with the disease process in subjects with the juvenile form of neuronal ceroid lipofuscinosis was discovered in 1995, our... Although the CLN3 gene associated with the disease process in subjects with the juvenile form of neuronal ceroid lipofuscinosis was discovered in 1995, our... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 81 |
SubjectTerms | Antisense Elements (Genetics) Antisense experiments Cell culture Child CLN3 Humans In Vitro Techniques Kidney - cytology Membrane Glycoproteins Microscopy, Confocal Molecular Chaperones Mutation, Missense Mutations Neuroblastoma Neuronal Ceroid-Lipofuscinoses - genetics Neuronal Ceroid-Lipofuscinoses - metabolism Neurons - cytology Neurons - enzymology Overexpression Proteins - analysis Proteins - genetics Proteins - metabolism Transfection Tumor Cells, Cultured |
Title | CLN3 disease process: missense point mutations and protein depletion in vitro |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S1090379805800169 https://dx.doi.org/10.1053/ejpn.2000.0440 https://www.ncbi.nlm.nih.gov/pubmed/11589014 https://www.proquest.com/docview/72182180 |
Volume | 5 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR3LSsQwMCwK4kV8vzUHwVNsa5I29bYsyvrYveiCt5K2KVQ0Lbtdj367M324eFgPQg9tmLRhZjIz6bwIufBjzZM4UUwZGTCRhS4LfWlYKgXXIuBBqvF_x2jsDyfi4VW-9sigy4XBsMpW9jcyvZbW7YjTYtMp89x5xpBCHoTKlQoNF0ziE_B24Omrr0WYRyjqlmsIzBC6K9wouWPeyroCqnuFfZeXKaZlhmetgO42yUZrOdJ-s7gt0jN2m6yNWt_4DhkNnsactg4XWjYJADf0Ax3uFkeK3Fb0Y9743mdU25TWVRpyS1NTYhHuwlJ4-MyrabFLJne3L4Mha5slsIS71xUDu0KncJjKMqGzFLCXyVh5HBU6zzKewMYNA24ST2i409dJmvI67RWOo1rD3t4jK7aw5oDQQGpfaQ9o5cYi1r4OfVBisYemFPYYOiSsw1SUtJXEsaHFe1R7tCWPELPY4NKNELOH5PIHvmxqaCyFdDrER11mKMiyCMT70hnez4xffPPnnPOOphEQAT0k2ppiPosCrGfvKYDYb0i9WK8nFXqcj_7xvWOy3kSu4XVCVqrp3JyCKVPFZzWvnpHV_v3jcPwNN1rwkQ |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV07T8MwELagSMCCeL-pByQmk6S282BDFVWBpgutxGY5iSMFgRNByshvx5dHEUMYkDIk1lmx7py7c757IHTpRpLGUewTX3GPsDSwSeByRRLOqGQe9RIJ_zvCqTues4dn_ryChm0uDIRVNrq_1umVtm5GrIabVpFl1hOEFFIv8G3ug-MSrKI1xqkHcX3XXz9xHgGreq4BNQHytnIjp5Z6KaoSqPY1NF7uskxdnmdlgUbbaKtxHfFtvbodtKL0LloPG3B8D4XDyZTiBnHBRZ0BcIPfAHHXMJJnusRvixp8_8BSJ7gq05BpnKgCqnDnGpuHz6x8z_fRfHQ3G45J0y2BxNQelMQ4FjIxp6k0ZTJNDPtSHvkOBYtO05TG5ssNPKpih0lzJwdxktAq79WcR6U0H_cB6ulcqyOEPS5dXzpGWHbEIunKwDVWLHLAl4ImQ8eItJwScVNKHDpavIoK0uZUAGehw6UtgLPH6GpJX9RFNDoprZbxok0NNcpMGP3eOcNZzvi1cf6c029lKowQACKRWuWLD-FBQXvHNxSHtah_1utwHyDnk3-8r482xrNwIib308dTtFmHscF1hnrl-0KdG7-mjC6qffsNytryJA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=CLN3+disease+process%3A+missense+point+mutations+and+protein+depletion+in+vitro&rft.jtitle=European+journal+of+paediatric+neurology&rft.au=Golabek%2C+Adam+A.&rft.au=Kida%2C+Elizabeth&rft.au=Walus%2C+Mariusz&rft.au=Kaczmarski%2C+Wojciech&rft.date=2001&rft.pub=Elsevier+Ltd&rft.issn=1090-3798&rft.eissn=1532-2130&rft.volume=5&rft.spage=81&rft.epage=88&rft_id=info:doi/10.1053%2Fejpn.2000.0440&rft.externalDocID=S1090379805800169 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1090-3798&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1090-3798&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1090-3798&client=summon |